Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Top Cited Papers
Open Access
- 20 December 2001
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (25), 1809-1817
- https://doi.org/10.1056/nejmoa003199
Abstract
Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies.Keywords
This publication has 39 references indexed in Scilit:
- Inhibitor-Induced Changes in the Intrinsic Fluorescence of Human Cyclooxygenase-2Biochemistry, 1996
- The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthaseNature Structural & Molecular Biology, 1995
- The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1Nature, 1994
- Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarctionEuropean Heart Journal, 1993
- Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonistsThe American Journal of Cardiology, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJCI Insight, 1982
- Estimated rate of prostacyclin secretion into the circulation of normal man.JCI Insight, 1981